Envision Healthcare Reports Second Quarter Adjusted EBITDA of $162.8 Million, up 21% on Strong Revenue Growth and Adjusted EPS Increases by 32%

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. ANET
3. NKE
4. PANW
5. CL
6. SNDK
7. TAP
8. DELL
9. ROIV
10. HUBS

Go back to Envision Healthcare Reports Second Quarter Adjusted EBITDA of $162.8 Million, up 21% on Strong Revenue Growth and Adjusted EPS Increases by 32%

Piper Jaffray Raises Price Target on Envision Healthcare (EVHC) Following 2Q EPS Beat

July 31, 2015 10:41 AM EDT

Piper Jaffray reiterated an Overweight rating on Envision Healthcare (NYSE: EVHC), and raised the price target to $45.00 (from $42.00), following 2Q results. EPS of $0.37 was $0.02 higher than consensus of $0.35.Revenue increased 25.9% y/y to $1,354M, which was $50M higher than consensus of $1,304M.... More

Envision Healthcare (EVHC) Tops Q2 EPS by 2c; Will Acquire Rural/Metro in $600M Deal

July 30, 2015 4:52 PM EDT

Envision Healthcare (NYSE: EVHC) reported Q2 EPS of $0.37, $0.02 better than the analyst estimate of $0.35. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.3 billion.

The company also has entered into a definitive agreement to acquire Rural/Metro Corporation (Rural/Metro) through its medical transportation segment American Medical Response (AMR). This pending acquisition enhances Envisions mobile integrated healthcare delivery capability, a key component of its care coordination model amongst its pre-hospital, acute care and post-acute care services.

Rural/Metro is expected to generate annualized 2015 revenue of approximately $600... More